Podcast

AMCP Podcast Series — Listen Up!

Delve deep into today’s challenges, trends, and opportunities in managed care pharmacy.

Unscripted – The AMCP Podcast: AI in Managed Care Pharmacy: Ethics, Efficiency & Patient Empowerment

13:34
Artificial Intelligence (AI)
Join us on this episode of Unscripted, the AMCP Podcast, as we explore the emerging role of artificial intelligence in managed care pharmacy. Our guest, Joe Honcz, RPh, MVA, MBA and Senior Vice President of Market Access at Petauri, shares insights from his time at Aetna’s Innovation Lab through to today’s cutting-edge applications—from AI-powered health concierges to streamlined prior authorizations and precision drug discovery. Discover how AI is transforming efficiency, patient empowerment, and the future of pharmacy practice.
Unscripted - The AMCP Podcast
AMCP Legislative Update: Key Policy Priorities Part 1
Legislation & Regulation

AMCP Legislative Update: Key Policy Prio...

Health care expert Fred Goldstein sits down with Adam Colborn, director of government affairs at AMCP, to discuss AMCP’s federal policy priorities in the 118th Congress.

17:00
Is Now the Time for Prescription Digital Therapeutics?
Prescription Digital Therapeutics

Is Now the Time for Prescription Digital...

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! speaks with Dr. Scott Whittle from Meridian Solutions about the pathways to bringing app-based prescription digital therapeutic solutions to health care.

15:20
Distinguished Service Awardees Reflect on Their Journey of Service to AMCP
Managed Care Practice Issues

Distinguished Service Awardees Reflect o...

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up!, sits down with Marissa Schlaifer and Billy West, AMCP Distinguished Service Award recipients, to discuss the role of AMCP in their careers.

17:51
Fundamentals of Managed Care Pharmacy Training Program
Managed Care Practice Issues

Fundamentals of Managed Care Pharmacy Tr...

Host Fred Goldstein invites Ruby Singh, Senior Vice President of Education and Instruction and Brittany Henry, Director of Education Programs, with AMCP, to discuss the brand-new 3rd edition of the AMCP Fundamentals of Managed Care Pharmacy Training Program scheduled for release July 2023.

10:48
AMCP Format for Formulary Submissions v4.1 Revisions: Public Comment Period

AMCP Format for Formulary Submissions v4...

Don't miss out on your chance to comment! Health care expert Fred Goldstein sits down with Ellen Whipple, BS Pharm, PharmD, to discuss the AMCP Format revision focused on digital therapeutics, health disparities, real-world evidence, PIE Deck guidance, and streamlining dossier development.

9:06
Capitol Hill PBM Reforms

Capitol Hill PBM Reforms

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent action on Capitol Hill surrounding pharmacy benefit manager reform.

16:21
Unpacking the CMS Guidance on Drug Negotiation, Part 2

Unpacking the CMS Guidance on Drug Negot...

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.

20:22
Unpacking the CMS Guidance on Drug Negotiation, Part 1

Unpacking the CMS Guidance on Drug Negot...

Health care expert Fred Goldstein, host of the AMCP Podcast Series — Listen Up! sits down with Melissa Andel, Principal and Founder of CommonHealth Solutions to take a closer look at the recent CMS guidance on drug price negotiation for 2026.

19:31
Humira Biosimilars are Here! What Now?
Biosimilars

Humira Biosimilars are Here! What Now? ...

Health care expert Fred Goldstein sits down with Melissa Andel, principal and founder of CommonHealth Solutions, to discuss the long-awaited launch of Humira biosimilars and what Amgen’s pricing strategy means for patients and payers.

16:28
The Buzz Around Biosimilars: AMCP’s Actions for 2023
Biosimilars

The Buzz Around Biosimilars: AMCP’s Acti...

2023 will be a pivotal year for biosimilar success or failure. Health care expert Fred Goldstein sits down with Stanton Mehr of Biosimilars Review & Report, to discuss what lies in store for biosimilars and AMCP’s biosimilar initiatives this year.

10:53